Research output per year
Research output per year
Personal profile
Interests
Dr. Greene completed her PhD within the School of Pharmacy at Queen’s University Belfast, which focused on the therapeutic evaluation of a novel immunomodulatory nanoparticle in models of Acute Respiratory Distress Syndrome. Within her present role as a postdoctoral researcher, Dr. Greene has continued to apply her expertise in nanomedicine, particularly in the field of oncology. She is currently engaged in a US-Ireland R&D Partnership Programme that aims to develop more effective therapies for pancreatic cancer, by combining nanomedicines with agents that can overcome the drug delivery barriers posed by the tumour microenvironment.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Michelle Greene is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Carbon nanotubes activate inflammatory signalling through binding to Siglec-14
Greene, M. K. & Scott, C. J., 14 Jun 2023, In: Nature Nanotechnology. 18, 6, p. 544-545 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Modular chemical construction of IgG-like mono- and bispecific synthetic antibodies (SynAbs)
Thoreau, F., Szijj, P. A., Greene, M. K., Rochet, L. N. C., Thanasi, I. A., Blayney, J. K., Maruani, A., Baker, J. R., Scott, C. J. & Chudasama, V., 22 Mar 2023, In: ACS Central Science. 9, 3, p. 476-487 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile15 Downloads (Pure) -
PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration (AMD)
Krishnan, A., Sendra, V. G., Patel, D., Lad, A., Greene, M. K., Smyth, P., Gallaher, S. A., Herron, Ú. M., Scott, C. J., Genead, M. & Tolentino, M., 23 Oct 2023, (Accepted) In: Frontiers in Immunology.Research output: Contribution to journal › Article › peer-review
-
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors
McDaid, W. J., Lissin, N., Pollheimer, E., Greene, M., Leach, A., Smyth, P., Bossi, G., Longley, D., Cole, D. K. & Scott, C. J., 20 Aug 2021, (Early online date) In: Nanoscale. 13, 35, p. 15010-15020Research output: Contribution to journal › Article › peer-review
Open AccessFile77 Downloads (Pure) -
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
Greene, M. K., Johnston, M. C. & Scott, C. J., 07 Dec 2021, (Early online date) In: Cancers. 13, 24, 26 p., 6175.Research output: Contribution to journal › Review article › peer-review
Open AccessFile148 Downloads (Pure)